$BIIB Headlines One lesson for investors from the 1990s

New Post Public Reply Private Reply Replies (0) Message Board

Jun 30, 2014 at 1:31 PM

$BIIB Headlines

One lesson for investors from the 1990s bubble 3:13 p.m. June 19, 2014 - The Trading Deck
Tyson rallies after jumping into Hillshire chase 3:44 p.m. May 29, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 3:52 p.m. May 12, 2014 - Sue Chang
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Internet, biotech could spawn next Apple: Allianz CIO 7:12 a.m. April 29, 2014 - Barbara Kollmeyer
Investors gloss over Biogen earnings miss and focus on MS drug sales 2:23 p.m. April 23, 2014 - Russ Britt
Scouring the moonscape for leading stocks 3:02 p.m. April 22, 2014 - The Trading Deck
Apple, Microsoft are not the keys to this week’s news 7:00 a.m. April 22, 2014 - Marek Fuchs
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
Biotech misses out on Nasdaq rally, sinks further into bear ground 4:58 p.m. April 14, 2014 - Russ Britt
Herbalife sinks on probe fears; Zoe’s surges on debut 4:37 p.m. April 11, 2014 - Sue Chang
Stocks fall for 3rd day in row; S&P 500 down for year again: stock market live blog recap 4:11 p.m. April 7, 2014 - blogs.marketwatch.com
Biotech bargain? 11:44 a.m. April 1, 2014 - The Trading Deck
Facebook, Biogen, Cal-Maine are stocks to watch 5:22 a.m. March 31, 2014 - Victor Reklaitis
U.S. stocks end week with losses 7:18 p.m. March 28, 2014 - Anora Mahmudova
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - Russ Britt
U.S. stocks fall; Nasdaq skids 1.2% 4:41 p.m. March 24, 2014 - Anora Mahmudova
Biotech has second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - Russ Britt
First Solar extends winning streak; Symantec plunges 3:07 p.m. March 21, 2014 - Sue Chang

3 Stocks Underperforming Today In The Drugs Industry 27 min ago - TheStreet.com
UCB's Vimpat Positive for Partial-Onset Seizures - Analyst Blog 11:50 a.m. Today - Zacks.com
Celladon Corporation (CLDN) Jumps: Stock Rises 5.3% - Tale of the Tape 9:21 a.m. Today - Zacks.com
Discovery Laboratories Inc. (DSCO) in Focus: Stock Rises 7.83% - Tale of the Tape 8:44 a.m. Today - Zacks.com
BioDelivery Progresses with Clonidine Late-Stage Study - Analyst Blog 6:00 p.m. June 27, 2014 - Zacks.com
Coronado Falls on TSO Study Results - Analyst Blog 11:20 a.m. June 27, 2014 - Zacks.com
Auxilium/Sobi's Xiapex Filed for Label Expansion - Analyst Blog 5:00 p.m. June 26, 2014 - Zacks.com
Hottest Healthcare Stocks Now – PCRX ISRG SHPG BIIB 2:15 p.m. June 26, 2014 - InvestorPlace.com
Biogen Idec Has Lagged Its Biotech Peers, Now Is The Time To Shine! 11:17 a.m. June 26, 2014 - Seeking Alpha
Bristol-Myers Up on Nivolumab News - Analyst Blog 10:45 a.m. June 26, 2014 - Zacks.com
Prothena Corporation (PRTA) Falls: Stock Goes Down 5.3% - Tale of the Tape 8:43 a.m. June 26, 2014 - Zacks.com
Isis Pharma Gets $1M Milestone Payment from Glaxo - Analyst Blog 6:10 p.m. June 25, 2014 - Zacks.com
Ligand Pharma-TG Therapeutics Collaborate on IRAK4 Inhibitors - Analyst Blog 4:30 p.m. June 25, 2014 - Zacks.com
AbbVie Sets Rationale for Shire Bid 1:06 p.m. June 25, 2014 - The Wall Street Journal Interactive Edition
British Columbia to Reimburse TECFIDERA(TM), a First-Line Oral Treatment for Multiple Sclerosis 11:00 a.m. June 25, 2014 - CNW Group
XenoPort's XP23829 in Phase II Study - Analyst Blog 4:52 p.m. June 24, 2014 - Zacks.com
Insider Trading Alert - BIIB, FDS And GCO Traded By Insiders 10:45 a.m. June 24, 2014 - TheStreet.com
Stocks with Upgraded Broker Ratings - Screen of the Week 4:05 a.m. June 24, 2014 - Zacks.com
3 Stocks Reiterated As A Buy: MDLZ, BMY, BIIB 4:29 p.m. June 23, 2014 - TheStreet.com
AbbVie, Shire Give Bullish Guidance Amid Buyout Talk 10:24 a.m. June 23, 2014 - Investors Business Daily

Critical Alerts For Vertex Pharmaceuticals, Dollar Tree, Avis, Ryder, and Biogen Released By InvestorsObserver 9:31 a.m. June 25, 2014 - PR Newswire - PRF
True North Therapeutics Announces $22 Million Series A Financing 7:00 a.m. June 17, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $10 Million Milestone Payment from Biogen Idec 7:00 a.m. June 17, 2014 - PR Newswire - PRF
Biogen Idec and AbbVie Announce Positive Top-Line Results from Phase 3 Study Investigating Daclizumab High-Yield Process in Multiple Sclerosis 7:30 a.m. June 16, 2014 - BusinessWire - BZX
Sobi to review preclinical data to potentially add future haemophilia A candidate to collaboration agreement with Biogen Idec 2:01 a.m. June 16, 2014 - Thomson Reuters ONE
One Year Post-Launch, All Surveyed U.S. Neurologists Report Having Clinical Experience with Biogen Idec's Tecfidera for the Treatment of Multiple Sclerosis 12:00 p.m. June 12, 2014 - PR Newswire - PRF
FDA Drug Approvals, Dividends, Fast Track Designation, Event Sponsorship, and Expansion of Role - Analyst Notes on Biogen Idec, UnitedHealth Group, GW Pharmaceuticals, Questcor and Cigna 5:10 a.m. June 11, 2014 - PR Newswire - PRF
RBCC to Expand Market for 'Underused' Addiction Treatment With New Technology 5:00 a.m. June 11, 2014 - BusinessWire - BZX
The Pulmonary Fibrosis Foundation Receives Grant From Biogen Idec To Support The PFF Patient Registry 11:00 a.m. June 10, 2014 - PR Newswire - PRF
Increased Credit Facility Commitments, Positions Moved, Survey Results, LEED Certification, and New Board Member Election - Analyst Notes on Prospect, Waddell & Reed, SEI, Alexandria and RPAI 5:20 a.m. June 10, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-DMPK Rx to Treat Myotonic Dystrophy Type 1 7:00 a.m. June 9, 2014 - PR Newswire - PRF
The US Food and Drug Administration (FDA) approves Eloctate(TM) 2:02 a.m. June 9, 2014 - Thomson Reuters ONE
FDA Approves Biogen Idec’s ELOCTATE™, First Hemophilia A Therapy to Extend the Interval between Prophylactic Infusions, for Both Adults and Children 4:55 p.m. June 6, 2014 - BusinessWire - BZX
FDA Approves Biogen Idec’s ELOCTATE™, First Hemophilia A Therapy to Extend the Interval between Prophylactic Infusions, for Both Adults and Children 4:46 p.m. June 6, 2014 - BusinessWire - BZX
Human Metabolome Technologies, Inc., (HMT) Hires Alexander Buko Ph.D. as Vice President, Business and Product Development and Releases a New C13 Flux Analysis Service, F-SCOPE. 3:27 p.m. June 6, 2014 - BusinessWire - BZX
Technical Snapshot on Biotech Stocks -- Research on Aegerion Pharma, Biogen Idec, Lexicon Pharma, and Curis 8:30 a.m. June 5, 2014 - PR Newswire - PRF
Critical Alerts For Tesla, Apple, Ryder System, ExOne, and Biogen Idec Released By InvestorsObserver 9:31 a.m. June 3, 2014 - PR Newswire - PRF
Upcoming Shareholders Meeting, Multi-Choice Medical Plans, FDA Approvals, and Investor Conference Schedules - Analyst Notes on Biogen Idec, UnitedHealth Group, Amgen, WellPoint and Mylan 7:00 a.m. June 3, 2014 - PR Newswire - PRF
Alexandria Real Estate Equities, Inc. Receives LEED Gold Certification for Biogen Idec Inc.'s Build-to-Suit Headquarters in Cambridge, Massachusetts 8:30 a.m. June 2, 2014 - PR Newswire - PRF
Data from Biogen Idec’s Portfolio of Multiple Sclerosis Therapies and Pipeline Featured at Medical Congresses 7:30 a.m. May 30, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Buy-Side Index Reveals State Market Variance

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Oil Markets Shift Focus: Pipelines Trump Drilling

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

NYSE Reflects on 9/11: Honoring Lives and Legacy

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...

High-Grade Copper Spurs Optimism for PolarX in Alaska

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...

Jari Spirits Set to Shake Up U.S. Market After Big Wins

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

Modeling and Mental Health Join Forces for Wellness

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

QuickFi Nabs Top Finovate Award for Fourth Time

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

Melissa Rivers Brings Her Wit Back to Emmys Carpet

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Lick the Plate Hits 2,000 Shows with Clown Band

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

DCM Services Teams with AKUVO to Boost Estate Recoveries

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...